BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2014
View Archived Issues
Apceth begins first human trial of genetically modified MSCs in cancer
Read More
Experience with tau-binding radiotracer [18F]T-807 accumulates
Read More
CHMP issues opinion on ataluren in nonsense mutation DMD
Read More
Researchers at Lundbeck present new nAChR PAMs
Read More
Endocyte provides update on MAAs for vintafolide and etarfolatide
Read More
GSK receives positive CHMP opinion for albiglutide in type 2 diabetes
Read More
Novel orexin receptor antagonists designed at Heptares Therapeutics
Read More
GSK reports data from phase III study of Tafinlar and Mekinist in melanoma
Read More
Canadian group discloses novel BTK inhibitors
Read More
hHR21 expression linked to prognosis in patients with colorectal cancer
Read More
Japanese researchers divulge new sst2 receptor agonists
Read More
Researchers at Esteve have patented novel sigma1R ligands
Read More
Crown Bioscience discloses novel kinase inhibitors for cancer
Read More
NIBIO, Aeras and Create form global collaboration to advance new mucosal TB vaccines
Read More
EMA committee recommends approval of Finox Biotech's biosimilar FSH
Read More
Roche's subcutaneous MabThera recommended for approval by CHMP
Read More
Lurasidone recommended for treatment of schizophrenia by EMA advisory committee
Read More
EMA committee recommends against approval of Nerventra for relapsing-remitting MS
Read More
Pacgen to sublicense global rights to antimicrobial peptide to GBC
Read More
mRNAs investigated as biomarkers in pancreatic neuroendocrine tumors
Read More
EMA committee advises against approval of masitinib for advanced pancreatic cancer
Read More
Nihon Medi-Physics launches DatSCAN in Japan
Read More
Phase I/II study of OPB-111001 recruiting patients with advanced cancer
Read More
Phase I study of novel treatment candidate for alcoholism begins patient recruitment
Read More
EMA committee recommends approval of Bayer's riociguat for two forms of pulmonary hypertension
Read More